4-(1,3,4-Oxadiazol-2-yl)aniline → 4-(4-(1,3,4-oxadiazol-2-yl)phenylamino)-2-((1R,2S)-2-aminocyclohexylamino)pyrimidine-5-carboxamide
反応式
[NH2:1][C@H:2]1[CH2:7][CH2:6][CH2:5][CH2:4][C@H:3]1[NH:8][C:9]1[N:14]=[C:13]([NH:15][C:16]2[CH:21]=[CH:20][C:19]([C:22]3[O:26]N=CC=3)=[CH:18][CH:17]=2)[C:12]([C:27]([NH2:29])=[O:28])=[CH:11][N:10]=1.O1C=[N:33][N:32]=[C:31]1C1C=CC(N)=CC=1>>[O:26]1[CH:31]=[N:32][N:33]=[C:22]1[C:19]1[CH:18]=[CH:17][C:16]([NH:15][C:13]2[C:12]([C:27]([NH2:29])=[O:28])=[CH:11][N:10]=[C:9]([NH:8][C@@H:3]3[CH2:4][CH2:5][CH2:6][CH2:7][C@@H:2]3[NH2:1])[N:14]=2)=[CH:21][CH:20]=1参加物
3
実験手順
This compound was synthesised using the synthetic scheme described for the synthesis of compound 122, and using 4-(1,3,4-oxadiazol-2-yl)aniline in step 1. MS: 395.3 (M+H).
後処理
- customThis compound was synthesised